ArticleGland surgery2020

Neoadjuvant docetaxel with or without carboplatin plus dual HER2 blockade for HER2-positive breast cancer: a retrospective multi-center Chinese study.

Minhao Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.